What is the purpose of this trial?
The main purpose of this study is to compare how long patients with glioblastoma (GBM, a malignant brain cancer) live after receiving nivolumab every two weeks in addition to radiation therapy (RT), and then every four weeks, compared with patients receiving standard therapy with temozolomide in addition to RT.
Bristol-Myers Squibb Company
Dates: 09/12/2016 - 03/01/2019
Last Updated: 02/22/2018
Study HIC#: 1604017516